Latest from Incanthera

Latest from Incanthera

January 28th, 2015 Successful Fundraising, Acquisition of New Drug Programme, Acquisition of Spear Therapeutics Limited
August 20th, 2014 ICT01 – patent granted in Japan
June 23rd, 2014 Company starts preclinical development of ICT03-Es5 agent
May 15th, 2014 Company secures IP protection in Japan for ICT01
April 20th, 2014 Company appoints new Chiarman
April 10th, 2014 ICT01 US Patent Granted